Dirk R. Wijnen schreef:
Een lange neus naar Viesbacher?
Dit had er met Crucell moeten gebeuren, maar klooster Leiden wil dat natuulijk niet.
...
Takeda Pharmaceutical Co. (4502.TO) is in talks to buy U.S.-based biotechnology company Genzyme Corp. (GENZ) for more than $18.5 billion, or Y1.525 trillion, U.K. newspaper The Mail reported Sunday citing a source close to the matter.
Genzyme...is looking for a higher offer after France's Sanofi-Aventis S.A. (SAN.FR) launched a hostile bid last month at $69 per share, the newspaper said.
Genzyme ... has approached several large drugs firms in recent weeks to act as a white knight, including GlaxoSmithKline PLC (GSK.LN), Eli Lilly & Co. (LLY) and Pfizer Inc. (PFE).
...